Amakem NV Information

Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases. Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.

Website	https://www.amakem.com
Revenue	$6.2 million
Employees	1 (0 on RocketReach)
Founded	2010
Address	Bioville Agoralaan Bldg a Bis, Diepenbeek, Flanders 3590, BE
Phone	+32 11 28 69 82
Technologies	JavaScript , HTML , Google Analytics +9 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Drug Stores & Pharmacies, Drug Discovery, Research, Retail, Science and Engineering, Kinase Inhibitors, Medical, Medicinal Chemistry, Health Care, Opthalmology, Therapeutics, Lung diseases, Inflammatory bowel disease
Keywords	Kinase Inhibitors, Biopharmaceutical, Drug Development, Bowel Disease Treatment, Crohn's Disease Treatment, Eye Disease Treatment, Diabetic Retinopathy Treatment, Lung Disease Treatment, Asthma Treatment, Targeted Therapy, Precision Medicine, Pharmaceutical Research
Competitors	Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim +50 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies